Market instability expected from South Korea’s new pricing reform in 2026-2028
Every two years, South Korea adjusts the national health insurance (NHI) prices for existing listed products based on the actual
Read MoreEvery two years, South Korea adjusts the national health insurance (NHI) prices for existing listed products based on the actual
Read MoreBy Michael Erman SAN FRANCISCO, Feb 11 (Reuters) – Some pharmaceutical companies not targeted by President Donald Trump for agreements
Read MoreUnder the three-year deal, AbbVie agreed to lower prices on certain Medicaid drugs and expand distribution through the TrumpRx direct-to-patient
Read MoreLilly’s Orna acquisition will see the company throw its hat into the in vivo cell therapy ring, which is garnering
Read MoreColombia hosts 90 Indian pharma executives to boost generic medicine supply, lower costs and explore local factory investments. Credit: Kristoferb
Read MoreThe interim India-US trade agreement is expected to strengthen cooperation in pharmaceuticals and medical technology, with industry bodies saying medicine
Read MoreThe SEC sued a Kentucky pharmaceutical company and two former executives for allegedly misleading investors about a cancer drug’s FDA
Read MoreThis past December, thought leaders in the pharma trade space converged at the W Philadelphia for Informa Connect’s Trade &
Read MoreThe Federal Trade Commission said Wednesday that it had settled a lawsuit against Express Scripts, one of the largest pharmacy
Read MorePfizer and investors alike look forward to further developments within the pharma’s newly acquired obesity portfolio. Image credit: ShU studio
Read More